CITY THERAPEUTICS files S-8 form
- Filed on 2026-10-16
- Incorporates previous filings
- Details on director indemnification
CTY
CITY THERAPEUTICS, INC. SEC filings
Every EDGAR filing for CITY THERAPEUTICS, INC. (CTY), newest first, with AI summaries and stories.
- Ticker
- CTY
- CIK
- 2143850
- Latest filing
- 2d
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINES-8CITY THERAPEUTICS, INC.CTYLIVE ROUTINE424B4CITY THERAPEUTICS, INC.CTYLIVE CITY THERAPEUTICS, INC. goes public
- 11,111,111 shares offered
- IPO price of $18.00 per share
- Listed on Nasdaq under CTY
ROUTINEEFFECTCITY THERAPEUTICS, INC.CTYLIVE CITY THERAPEUTICS, INC. files S-1 form.
- Filed on 2026-10-15.
- Form S-1 submitted.
- Effectiveness date: October 15, 2026.
ROUTINES-1MEFCITY THERAPEUTICS, INC.CTYLIVE CITY THERAPEUTICS files S-1MEF
- Filed on 2026-10-15
- Adds 1,597,222 shares
- 208,333 shares under underwriters option
ROUTINE3CITY THERAPEUTICS, INC.CTYLIVE 11 insider filings
Keith Crandell, new insider at CTY
Show all 11
- 3New insider at CTY
- 3New insider at CTY
- 3New insider at CTY
- 3New insider at CTY
- 3New insider at CTY
- 3New insider at CTY
- 3New insider at CTY
- 3New insider at CTY
- 3New insider at CTY
- 3New insider at CTY
- 3New insider at CTY
Keith Crandell, reporting · Steven Gillis, reporting · +4 more
ROUTINECERTCITY THERAPEUTICS, INC.CTYLIVE CITY THERAPEUTICS, INC. files Form CERT
- Form CERT filed on 2026-10-15
- Document contains identity and Adobe information
- Stream data includes technical details
ROUTINE8-A12BCITY THERAPEUTICS, INC.CTYLIVE CITY THERAPEUTICS, INC. files Form 8-A12B
- Filed on 2026-10-13
- Registered common stock on Nasdaq
- No other securities registered
ROUTINES-1/ACITY THERAPEUTICS, INC.CTYLIVE City Therapeutics files S-1/A for IPO
- Filed S-1/A on 2026-10-09
- Offering 9,722,222 shares of common stock
- Estimated IPO price per share between $17.00 and $19.00
NOTABLES-1CITY THERAPEUTICS, INC.LIVE